CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Haleon Pakistan Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Haleon Pakistan Ltd
Sykes Building
, 35-Dockyard Road,, West Wharf
Phone: +92 21111475725p:+92 21111475725 KARACHI, 74000  Pakistan Ticker: HALEONHALEON
This is a Subsidiary, click here for the Parent Company
Business Summary
Haleon Pakistan Limited, formerly Glaxosmithkline Consumer Healthcare Pakistan Limited, is a Pakistan-based healthcare company. The Company's product portfolio consists of five categories, namely oral health, pain relief, respiratory health, digestive health, and other and vitamins, minerals and supplements (VMS). Its geographical segment consists of North America; Europe, Middle East and Africa (EMEA), and Latin America (LatAm), and Asia-Pacific (APAC). The Brands under Oral Health include Sensodyne, Parodontax, Polident, and Biotene. Its Vitamins, Minerals and Supplements offers a portfolio of brands, such as Centrum, a multivitamin and mineral brand; calcium supplements through its Caltrate brand, and vitamin C supplements through Emergen-C. The Brands under Respiratory consists of Otrivin, Theraflu, and Flonase. The Company's Pain Relief product includes Panadol, Voltaren, and Advil brands. Its portfolio digestive health brands consist of Eno, Tums, and Fenistil.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2834 Pharmaceutical preparations
2833 Medicinal chemicals and botanical products
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances
5122 Drugs, drug proprietaries, and druggists' sundries

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Independent Chairman of the Board M. Z. MoinMohajir 4/26/2018 4/26/2018
Chief Executive Officer, Executive Director Farhan MuhammadHaroon 4/1/2021
Chief Financial Officer, Finance Director, Executive Director DilawarMeghani 10/27/2020 10/27/2020
12 additional Officers and Directors records available in full report.

Business Names
Business Name
GSKCH
HALEON

General Information
Number of Employees: 481 (As of 12/31/2023)
Outstanding Shares: 117,054,508 (As of 9/30/2024)
Shareholders: 4,366
Stock Exchange: PSX
Fax Number: +92 2132314898


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024